Home›Companies›Biotech & Pharma›Q-Immune

Q-Immune, Inc.

Measures protein interactions inside living cells.

Updated Nov 9, 2026·Latest SEC filing Sep 28, 2026·Suggest an edit

About Q-Immune

Q-Immune is a private company based in Seattle, Washington, incorporated in 2025 in Washington. It has reported $25,000 raised in one offering on Form D since September 2026. Its chief executive is Cameron McCann.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 24, 2026Sep 28, 2026$25,000of $1.0M target1$25,000EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Q-Immune's Form D filed Sep 28, 2026.

SS
Stephen Paucha Smith
Executive officer and director
CM
Cameron McCann
CEO and director

Sources

  1. SECQ-Immune, Inc. filing history